This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: Q26.1 (Persistent left superior vena cava) | Special Copayment Reduction: V192 (Special copayment reduction for heart disease: 5% copayment for up to 30 days from the registration date) |
| B. Synonyms | PLSVC, persistent left superior vena cava, left superior vena cava persistence, double superior vena cava |
| C. Adult onset | Mostly asymptomatic and discovered incidentally on chest X-ray, echocardiography, central venous catheter insertion, or cardiac surgery. Because it is accompanied by coronary sinus dilation, abnormal findings are sometimes first detected on echocardiography. |
| 1. History | First described at autopsy in the 1850s; in 1903 Raghib et al. clinically described the type with direct drainage of the left superior vena cava into the coronary sinus |
| 2. Causes | Failure of regression of the fetal left anterior cardinal vein; a structure that should regress into the ligament of Marshall during normal development persists |
| 3. Genetics | Mostly sporadic; when accompanied by complex cardiac malformations, associated with the genetic factors of those malformations; rarely related to NKX2-5 and GATA4 |
| 4. General epidemiology | 0.3–0.5% of the general population; 4–10% in patients with congenital heart malformations; bilateral SVC is rarer than isolated PLSVC |
| 5. Pathophysiology | Partial or complete failure of regression of the left anterior cardinal vein causes the fetal left venous vessel to persist after birth |
| 6. Symptoms | Mostly asymptomatic; risk of cyanosis and paradoxical embolism in the type draining directly into the left atrium from the coronary sinus |
| 7. Signs | Dilated coronary sinus on echocardiography; abnormal (left-sided) position of a central venous catheter; abnormal shadow at the left atrial border on chest X-ray |
| 8. Screening | Echocardiography (screening for coronary sinus dilation); chest X-ray and echocardiography when an abnormal course is suspected after left subclavian or internal jugular insertion |
| 9. Diagnosis | Echocardiography (including bubble study), CT/MR angiography, cardiac catheterization (angiography), left central venous catheter angiography |
| 10. Treatment | Mostly no treatment needed; coronary sinus–left atrium communicating type: correction of the septal defect; careful approach when implanting a pacemaker/ICD |
| 11. Prognosis | Isolated PLSVC has a very good prognosis; risks of arrhythmia and paradoxical embolism reported in some |
| 12. Prevention | Prenatal fetal echocardiography; accurate anatomical confirmation is essential for interventional procedures and surgery after diagnosis |
| 13. References | Persistent Left Superior Vena Cava: Implications of Surgical Management … and 9 other papers |
Persistent left superior vena cava (PLSVC) is a thoracic venous anomaly in which the left anterior cardinal vein, which should disappear during normal fetal development, persists after birth, and it is the most common congenital thoracic venous malformation. The first systematic descriptions of this malformation were made in autopsy studies in the mid-19th century, when anatomists observed that a similar vessel existed on the left side in addition to the normal right superior vena cava. In 1903, Raghib et al. first clinically described a rare variant in which the left superior vena cava drains directly into the left atrium without passing through the coronary sinus (Raghib complex).
Until the early 20th century, PLSVC was known mainly as an autopsy finding, but with the development of surgery for congenital heart malformations in the 1950s–60s, handling of left systemic venous flow during surgery emerged as a clinical challenge. In particular, failure to recognize a left superior vena cava when setting up cardiopulmonary bypass can cause serious hemodynamic problems during surgery under general anesthesia, so the importance of preoperative anatomical assessment was emphasized. With advances in echocardiography in the 1970s–80s, coronary sinus dilation was recognized as an indirect marker of PLSVC, and the saline bubble injection test (bubble study) was subsequently established as a simple means of diagnosing PLSVC.
Since the 2000s, the widespread use of CT angiography and MR angiography has made it possible to precisely and noninvasively determine the entire anatomy of thoracic venous anomalies, including PLSVC. As permanent pacemaker and implantable cardioverter-defibrillator (ICD) procedures increased, the clinical importance of PLSVC was re-examined, and abnormal lead positioning with left subclavian and internal jugular approaches and abnormal pacing via the coronary sinus route emerged as new clinical challenges.
The cause of PLSVC is failure of regression of the left anterior cardinal vein during fetal development. In normal fetal development, the left anterior cardinal vein gradually regresses around 8–10 weeks of gestation and remains as the ligament of Marshall, a fibrous band running along the left atrioventricular groove of the heart. The ligament of Marshall is identifiable even in adults as a structure connecting the proximal coronary sinus and the lower left pulmonary veins. If this regression process is not completed, the left anterior cardinal vein remains a patent vessel, forming a PLSVC.
In PLSVC, flow in the left superior vena cava mostly drains into the right atrium via the coronary sinus (about 80–90%). In this case there is no hemodynamic abnormality and no clinical impact. Rarely (about 8–10%), however, the coronary sinus is absent or there is a defect in the roof between the left atrium and the coronary sinus, so that left superior vena cava flow drains directly into the left atrium—the Raghib complex—and in this case deoxygenated venous blood mixes into the systemic circulation, causing cyanosis. Cases without a right superior vena cava (isolated PLSVC) also rarely exist, in which all venous return from the head, neck, and upper limbs occurs through the left superior vena cava.
PLSVC mostly occurs sporadically, and when it occurs in isolation, no specific genetic cause is identified in most cases. However, when PLSVC accompanies complex congenital heart malformations (especially heterotaxy, left heart malformations, atrioventricular septal defects, etc.), the genetic factors of those malformations may increase the risk of associated PLSVC.
Some studies have reported cases of increased frequency of PLSVC in families carrying NKX2-5 variants, and a possible association with GATA4 variants has also been raised. PLSVC is very commonly present in heterotaxy syndrome, in which variants in left-right asymmetry genes such as ZIC3, CFC1, and NODAL cause venous malformations, including PLSVC, as part of the overall heterotaxy phenotype. There are also reports that the frequency of PLSVC is higher in Down syndrome than in the general population, suggesting that genetic factors related to chromosome 21 may affect venous development. Overall, the genetics of isolated PLSVC is a field that has not yet been sufficiently studied, and large-scale genomic analyses will be needed in the future.
PLSVC is the most common single malformation among thoracic venous malformations, with a prevalence of about 0.3–0.5% in the general population. This is the frequency with which it is found incidentally on chest CT or angiography even in a population without congenital heart malformations. In patients with congenital heart malformations, the prevalence is much higher, with PLSVC present in about 4–10%. In heterotaxy syndrome and the asplenia type, the incidence of PLSVC or bilateral SVC may approach 50%.
No significant sex difference has been reported, and it occurs with equal frequency in men and women. 'Isolated PLSVC without right SVC', in which the right superior vena cava is absent and only the left superior vena cava exists, accounts for about 10–18% of all PLSVC and has greater clinical significance. The form in which both SVCs exist simultaneously is the most common form of PLSVC, and it is divided into cases in which the innominate (brachiocephalic) vein connecting the left and right SVCs is absent or thin and cases in which it is present. Separate large-scale epidemiological studies on the prevalence of PLSVC in Asian countries, including Korea, are still lacking.
The pathogenesis of PLSVC is an abnormality in the formation of the venous system during embryonic development. In early fetal life, bilaterally symmetric anterior cardinal veins exist on each side, and they form the venous vascular structure through the common cardinal veins. Around 5–8 weeks of gestation, as the brachiocephalic vein forms between the left and right anterior cardinal veins, venous flow from the left upper body begins to be diverted to the right. Accordingly, the left anterior cardinal vein gradually regresses as its flow decreases and becomes the ligament of Marshall.
The molecular signals involved in this regression process have not yet been fully elucidated, but hemodynamic factors (vascular regression due to reduced flow) and genetic signals (FGF, VEGF, Notch pathways) are understood to be involved in combination. If regression is incomplete, the left anterior cardinal vein persists as a complete venous vessel, forming a PLSVC. In PLSVC, the coronary sinus roof between the left and right atria is usually intact, so left superior vena cava flow drains into the right atrium via the coronary sinus and there is no hemodynamic abnormality. However, when the coronary sinus roof is lacking or the coronary sinus is absent (Raghib complex), venous blood drains directly into the left atrium, causing cyanosis.
When the PLSVC drains normally into the right atrium via the coronary sinus (about 80–90%), there are no clinical symptoms at all and no hemodynamic abnormality. In this case, PLSVC is merely an anatomical variant of the venous system without physiological significance. Therefore, most patients are often unaware of their condition until it is discovered incidentally during imaging, surgery, or central venous catheter insertion.
In the rare (about 8–10%) Raghib complex (left superior vena cava draining directly into the left atrium + absent coronary sinus), the risks of cyanosis, paradoxical embolism, and stroke due to right-to-left shunting are increased. Paradoxical embolism can occur via a route by which venous thrombi enter the systemic circulation directly through the PLSVC. There are also reports that arrhythmias such as paroxysmal supraventricular tachycardia and atrial flutter are relatively common in patients with PLSVC, which is related to the role of ligament of Marshall tissue as an arrhythmogenic substrate. There are also studies suggesting that abnormal atrial tissue in the dilated coronary sinus accompanying PLSVC can be the origin of arrhythmias.
In asymptomatic PLSVC, the physical examination is normal. However, the following indirect clinical clues may be found. On the 4-chamber view of echocardiography, abnormal dilation of the coronary sinus is the most common indirect finding (normal diameter ≤1 cm, compared with 1.5–3 cm or more in PLSVC), and when it is found, PLSVC must be ruled out. In a saline bubble injection test (bubble study), a pattern in which bubbles injected into a left upper limb vein appear first in the right atrium via the coronary sinus confirms PLSVC.
When a central venous catheter or pacemaker lead is inserted via the left subclavian or left internal jugular vein, a characteristic course on chest X-ray in which the catheter runs downward along the left heart border and then turns toward the coronary sinus strongly suggests PLSVC. In this case the catheter lies within the coronary sinus rather than the right atrium, so pacing may be ineffective or there is a risk of coronary sinus perforation. With a Raghib complex, cyanosis is present and responds only partially to oxygen administration.
Screening for PLSVC is not intentionally performed in the general population in the absence of specific symptoms. However, PLSVC should be kept in mind and actively checked in the following clinical situations. First, when abnormal dilation of the coronary sinus is found on echocardiography, it is a direct indication for PLSVC screening. Coronary sinus dilation has causes other than PLSVC, such as coronary sinus ASD, coronary sinus–left atrium communication, and coronary artery fistula, so differentiation from PLSVC is needed.
Second, when the catheter course is abnormal (running downward along the left heart border) after insertion of a central venous catheter, pacemaker lead, or PICC line via the left subclavian or internal jugular vein, PLSVC should be suspected immediately and confirmatory imaging performed. Third, in patients with complex congenital heart malformations, the presence of PLSVC must be checked as part of preoperative assessment of venous anatomy. When coronary sinus dilation is found on prenatal fetal echocardiography, fetal diagnosis of PLSVC is also possible.
PLSVC is confirmed by imaging. On echocardiography, PLSVC is confirmed when, along with coronary sinus dilation, a saline bubble injection test (bubble study) shows bubbles in the right atrium via the coronary sinus after injection into a left upper limb vein. This test is noninvasive, fast, and highly reliable. Transesophageal echocardiography (TEE) provides clearer images of the coronary sinus and allows direct observation of left superior vena cava flow.
CT angiography (CTA) is the most comprehensive test, determining at once the entire course of the PLSVC, whether it drains into the coronary sinus, the presence of a right SVC, the presence of an innominate vein, and associated cardiac malformations. MR angiography (MRA) provides similar information without radiation and is preferred in children. Cardiac catheterization angiography is used for intravascular pressure measurement and oxygen saturation measurement through the PLSVC and to confirm whether there is a direct connection between the PLSVC and the coronary sinus or left atrium. When a PLSVC course is identified during pacemaker or ICD lead insertion, the position of the lead within the coronary sinus is confirmed on fluoroscopic contrast imaging.
A PLSVC draining normally into the right atrium via the coronary sinus has no hemodynamic abnormality, so no specific treatment is needed. However, depending on the clinical situation, important clinical measures may be required. Pacemaker or ICD lead insertion: when PLSVC is found during a left-sided approach, it should be assessed whether pacing via the coronary sinus (CS pacing) is possible, and in some patients a change to a right-sided approach or special techniques (guiding a coronary sinus lead into the right ventricle) are needed. In cardiac resynchronization therapy (CRT), left ventricular lead insertion via the PLSVC route is sometimes possible.
In the Raghib complex (left superior vena cava draining directly into the left atrium), there is a risk of cyanosis and paradoxical embolism due to right-to-left shunting, so surgical correction is indicated. Surgical methods include reconstructing the coronary sinus roof with an intra-atrial patch or connecting the PLSVC to the right SVC or right atrial appendage. During surgery for congenital heart malformations, when a PLSVC is present, an additional left vena cava cannula must be inserted or a bypass method applied when setting up cardiopulmonary bypass; if this is not identified in advance, hemodynamic instability and failure of myocardial protection may occur during surgery.
The prognosis of isolated PLSVC (draining into the right atrium via the coronary sinus) is very good. This form does not affect life expectancy and requires no specific follow-up. However, a record of the diagnosis is needed to prevent confusion when planning future central venous catheters, pacemakers, or surgery.
When PLSVC accompanies complex congenital heart malformations (heterotaxy, atrioventricular septal defect, single ventricle, etc.), the overall prognosis is determined by the severity of the underlying malformation and the surgical outcome. After correction of a Raghib complex, resolution of cyanosis and a reduced risk of paradoxical embolism are expected, but postoperative arrhythmias and coronary sinus dysfunction may occur, so follow-up is needed. The arrhythmia risk associated with PLSVC is still being studied, and PLSVC anatomy must be considered when planning catheter ablation for atrial fibrillation or tachycardia. Pregnancy is known to proceed normally in patients with isolated PLSVC.
PLSVC itself is a congenital venous malformation that cannot be prevented. However, clinical complications can be prevented. The most important preventive measure is to document the diagnosis in the medical record of patients diagnosed with PLSVC so that future operators are aware of it in advance. In particular, if PLSVC anatomy is not confirmed beforehand during left-sided central venous catheter insertion, pacemaker lead insertion, or thoracic surgery, procedural complications (coronary sinus perforation, abnormal lead position, incomplete cardiopulmonary bypass) may occur.
In patients with congenital heart malformations, the presence of PLSVC must be confirmed by preoperative CT/MR angiography and reflected in the surgical plan. In single-ventricle patients undergoing the Fontan operation, a PLSVC requires a bilateral bidirectional Glenn, in which each of the two SVCs is anastomosed in the superior cavopulmonary anastomosis (Glenn); failure to identify this in advance leads to incomplete surgery. In patients with a Raghib complex at risk of paradoxical embolism, minimizing risk factors for thrombus formation (dehydration, immobility, pregnancy, etc.) and performing immediate evaluation when symptoms occur are key to prevention.
Irwin RB, Greaves M, Schmitt M. Left superior vena cava: revisited. European Heart Journal: Cardiovascular Imaging. 2012;13(4):284–291. DOI: 10.1093/ehjci/jer191. PMID: 21979980.
Schreiber C, Vogt M, Bauernschmitt R, et al. Persistent left superior vena cava: implications of surgical management. Journal of Cardiac Surgery. 2019;34(9):830–836. DOI: 10.1111/jocs.14133. PMID: 31371908.
Biffi M, Boriani G, Frabetti L, et al. Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation. Chest. 2001;120(1):139–144. DOI: 10.1378/chest.120.1.139. PMID: 11451831.
Povoski SP, Khabiri H. Persistent left superior vena cava: review of the literature, clinical implications, and relevance of alterations in thoracic central venous anatomy as pertaining to the general principles of central venous access device placement and venography in cancer patients. World Journal of Surgical Oncology. 2011;9:173. DOI: 10.1186/1477-7819-9-173. PMID: 22166096.
Sarodia BD, Stoller JK. Persistent left superior vena cava: case report and literature review. Respiratory Care. 2000;45(4):411–416. PMID: 10780045.
Raghib G, Ruttenberg HD, Anderson RC, et al. Termination of left superior vena cava in left atrium, atrial septal defect, and absence of coronary sinus. Circulation. 1965;31:906–918. DOI: 10.1161/01.cir.31.6.906. PMID: 14298509.
Goyal SK, Punnam SR, Verma G, et al. Persistent left superior vena cava: a case report and review of literature. Cardiovascular Ultrasound. 2008;6:50. DOI: 10.1186/1476-7120-6-50. PMID: 18957069.
Mak GS, Hill AJ, Mokadam NA, et al. Persistent left superior vena cava and coronary sinus dilatation: clinical significance and literature review. Pacing and Clinical Electrophysiology. 2013;36(3):393–396. DOI: 10.1111/pace.12041. PMID: 23134526.
Baumgartner H, De Backer J, Babu-Narayan SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. European Heart Journal. 2021;42(6):563–645. DOI: 10.1093/eurheartj/ehaa554. PMID: 32860028.
Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease. Journal of the American College of Cardiology. 2008;52(23):e1–e121. DOI: 10.1016/j.jacc.2008.10.001. PMID: 19038677.